A phase 2, adaptive randomized, double-blind, placebo-controlled, multicenter, 52-week study of HM15211 in patients with biopsy-confirmed non-alcoholic steatohepatitis – Study design and rationale of HM-TRIA-201 study
Titel:
A phase 2, adaptive randomized, double-blind, placebo-controlled, multicenter, 52-week study of HM15211 in patients with biopsy-confirmed non-alcoholic steatohepatitis – Study design and rationale of HM-TRIA-201 study
Auteur:
Abdelmalek, Manal F. Suzuki, Ayako Sanchez, Willian Lawitz, Eric Filozof, Claudia Cho, Hyungjin Baek, Eunhye Choi, JaeDuk Baek, Seungjae